Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 176

1.

National treatment trends among older patients with T1-localized renal cell carcinoma.

Kim SP, Gross CP, Meropol N, Kutikov A, Smaldone MC, Shah ND, Yu JB, Psutka S, Kiechle J, Abouassaly R.

Urol Oncol. 2016 Nov 10. pii: S1078-1439(16)30315-5. doi: 10.1016/j.urolonc.2016.10.008. [Epub ahead of print]

PMID:
27839926
2.

Understanding Treatment Disconnect and Mortality Trends in Renal Cell Carcinoma Using Tumor Registry Data.

Smaldone MC, Egleston B, Hollingsworth JM, Hollenbeck BK, Miller DC, Morgan TM, Kim SP, Malhotra A, Handorf E, Wong YN, Uzzo RG, Kutikov A.

Med Care. 2016 Nov 4. [Epub ahead of print]

PMID:
27820596
3.

Men's health supplement use and outcomes in men receiving definitive intensity-modulated radiation therapy for localized prostate cancer.

Zaorsky NG, Churilla TM, Ruth K, Hayes SB, Sobczak ML, Hallman MA, Smaldone MC, Chen DY, Horwitz EM.

Am J Clin Nutr. 2016 Oct 26. pii: ajcn119958. [Epub ahead of print]

PMID:
27797706
4.

Prostate Cancer Patients With Unmanaged Diabetes or Receiving Insulin Experience Inferior Outcomes and Toxicities After Treatment With Radiation Therapy.

Zaorsky NG, Shaikh T, Ruth K, Sharda P, Hayes SB, Sobczak ML, Hallman MA, Smaldone MC, Chen DY, Horwitz EM.

Clin Genitourin Cancer. 2016 Sep 8. pii: S1558-7673(16)30254-3. doi: 10.1016/j.clgc.2016.08.020. [Epub ahead of print]

PMID:
27789181
5.

Difference of opinion - Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: No.

Ristau BT, Smaldone MC.

Int Braz J Urol. 2016 Sep-Oct;42(5):880-882. doi: 10.1590/S1677-5538.IBJU.2016.05.05. No abstract available.

6.
7.

Perioperative Outcomes Following Partial Nephrectomy Performed on Patients Remaining on Antiplatelet Therapy.

Ito T, Derweesh IH, Ginzburg S, Abbosh PH, Raheem OA, Mirheydar H, Hamilton Z, Chen DY, Smaldone MC, Greenberg RE, Viterbo R, Kutikov A, Uzzo RG.

J Urol. 2016 Jul 11. pii: S0022-5347(16)30770-4. doi: 10.1016/j.juro.2016.07.001. [Epub ahead of print]

PMID:
27418453
8.

Editorial Comment.

Cahn DB, Ristau BT, Uzzo RG, Smaldone MC.

Urology. 2016 Sep;95:101-2. doi: 10.1016/j.urology.2016.04.056. No abstract available.

PMID:
27372246
9.

Disparities in Treatment of Patients With High-risk Prostate Cancer: Results From a Population-based Cohort.

Wang EH, Yu JB, Abouassally R, Meropol NJ, Cooper G, Shah ND, Williams SB, Gonzalez C, Smaldone MC, Kutikov A, Zhu H, Kim SP.

Urology. 2016 Sep;95:88-94. doi: 10.1016/j.urology.2016.06.010.

PMID:
27318264
10.

Bladder Preservation Therapy: A Review of the Literature and Future Directions.

Cahn DB, Ristau BT, Ghiraldi EM, Churilla TM, Geynisman DM, Horwitz EM, Uzzo RG, Smaldone MC.

Urology. 2016 Oct;96:54-61. doi: 10.1016/j.urology.2016.05.041. Review.

PMID:
27257135
11.

NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.

Carroll PR, Parsons JK, Andriole G, Bahnson RR, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Farrington T, Hemstreet GP 3rd, Kawachi MH, Kim S, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Moses KA, Nadler RB, Poch M, Scales C, Shaneyfelt TM, Smaldone MC, Sonn G, Sprenkle P, Vickers AJ, Wake R, Shead DA, Freedman-Cass DA.

J Natl Compr Canc Netw. 2016 May;14(5):509-19.

PMID:
27160230
12.

Editorial Comment.

McHugh M, Smaldone MC.

J Urol. 2016 Aug;196(2):333-4. doi: 10.1016/j.juro.2016.02.2983. No abstract available.

PMID:
27125540
13.

Renal Mass Biopsy: Always, Sometimes, or Never?

Kutikov A, Smaldone MC, Uzzo RG, Haifler M, Bratslavsky G, Leibovich BC.

Eur Urol. 2016 Sep;70(3):403-6. doi: 10.1016/j.eururo.2016.04.001.

PMID:
27085625
14.

Effects of Time to Treatment on Biochemical and Clinical Outcomes for Patients With Prostate Cancer Treated With Definitive Radiation.

Dong Y, Li T, Churilla TM, Viterbo R, Sobczak ML, Smaldone MC, Chen DY, Uzzo RG, Hallman MH, Horwitz EM.

Clin Genitourin Cancer. 2016 Oct;14(5):e463-e468. doi: 10.1016/j.clgc.2016.01.014.

PMID:
26935996
15.

The role of radical prostatectomy in high-risk localized, node-positive and metastatic prostate cancer.

Ristau BT, Cahn D, Uzzo RG, Chapin BF, Smaldone MC.

Future Oncol. 2016 Mar;12(5):687-99. doi: 10.2217/fon.15.355.

PMID:
26839141
16.

Advanced small cell carcinoma of the bladder: clinical characteristics, treatment patterns and outcomes in 960 patients and comparison with urothelial carcinoma.

Geynisman DM, Handorf E, Wong YN, Doyle J, Plimack ER, Horwitz EM, Canter DJ, Uzzo RG, Kutikov A, Smaldone MC.

Cancer Med. 2016 Feb;5(2):192-9. doi: 10.1002/cam4.577.

17.

NCCN Clinical Practice Guidelines Prostate Cancer Early Detection, Version 2.2015.

Carroll PR, Parsons JK, Andriole G, Bahnson RR, Barocas DA, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Farrington T, Hemstreet GP 3rd, Kawachi MH, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Nadler RB, Poch M, Scales C, Shaneyfelt TM, Smaldone MC, Sonn G, Sprenke P, Vickers AJ, Wake R, Shead DA, Freedman-Cass D.

J Natl Compr Canc Netw. 2015 Dec;13(12):1534-61.

PMID:
26656522
18.

Radiation therapy to the primary tumor in locally advanced prostate cancer is not "closing the barn door after the horse has bolted".

Zaorsky NG, Hallman MA, Smaldone MC.

Ann Transl Med. 2015 Oct;3(18):274. doi: 10.3978/j.issn.2305-5839.2015.09.14. No abstract available.

19.

Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid Features.

Ito T, Pei J, Dulaimi E, Menges C, Abbosh PH, Smaldone MC, Chen DY, Greenberg RE, Kutikov A, Viterbo R, Uzzo RG, Testa JR.

J Urol. 2016 Apr;195(4P1):852-8. doi: 10.1016/j.juro.2015.10.180.

PMID:
26602888
20.

Contemporary Trends in the Utilization of Radiotherapy in Patients With Renal Cell Carcinoma.

Shaikh T, Handorf EA, Murphy CT, Kutikov A, Uzzo RG, Hallman M, Horwitz EM, Smaldone MC.

Urology. 2015 Dec;86(6):1165-73. doi: 10.1016/j.urology.2015.08.012.

PMID:
26383611
Items per page

Supplemental Content

Loading ...
Support Center